Institut Bergonié
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1923-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.bergonie.org
Immune Mechanisms After Radiofrequency Ablation of Pulmonary Metastases From Colorectal Cancer Origin
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-05-22
- Last Posted Date
- 2024-02-13
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 20
- Registration Number
- NCT03960021
- Locations
- 🇫🇷
Institut Bergonie, Bordeaux, France
Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors
- First Posted Date
- 2019-04-16
- Last Posted Date
- 2024-05-22
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 247
- Registration Number
- NCT03915678
- Locations
- 🇫🇷
Chu Brest, Brest, France
🇫🇷IUCT Oncopôle, Toulouse, France
🇫🇷Institut Bergonié, Bordeaux, France
Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2019-01-15
- Last Posted Date
- 2023-03-01
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 351
- Registration Number
- NCT03805022
- Locations
- 🇫🇷
CHU Dupuytren, Limoges, France
🇫🇷Institut Gustave Roussy, Villejuif, France
🇫🇷Centre Georges François Leclerc, Dijon, France
Access to Care and Prognosis in Elderly With Cancer (INCAPAC Study)
Completed
- Conditions
- First Posted Date
- 2018-10-03
- Last Posted Date
- 2023-07-05
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 450
- Registration Number
- NCT03694171
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
Efficacy Endpoints to Assess Treatment Efficacy in Randomized Controlled Trials in Elderly Cancer Patients
- First Posted Date
- 2018-09-18
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 28
- Registration Number
- NCT03676218
- Locations
- 🇫🇷
Institut Bergonié, Bordeaux, France
Trends in Modern Phase 1 Oncology Trials
Completed
- Conditions
- First Posted Date
- 2018-09-18
- Last Posted Date
- 2021-01-07
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 6915
- Registration Number
- NCT03676270
- Locations
- 🇫🇷
Insitut Bergonié, Bordeaux, France
Definition for the Assessment of Time-to-event Endpoints in CANcer Trials (DATECAN-1)
- First Posted Date
- 2018-09-18
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 196
- Registration Number
- NCT03676010
- Locations
- 🇫🇷
Centre Georges François Leclerc, Dijon, France
🇫🇷Institut du Cancer de Montpellier, Montpellier, France
🇫🇷Institut Bergonié, Bordeaux, France
Survival Endpoints for Treatment Evaluation in Subjects Treated for Metastatic Breast Cancer: Contribution of Real-life Databases
Active, not recruiting
- Conditions
- First Posted Date
- 2018-09-18
- Last Posted Date
- 2023-08-01
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 20000
- Registration Number
- NCT03676257
- Locations
- 🇫🇷
Insitut Bergonié, Bordeaux, France
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors
- First Posted Date
- 2018-03-23
- Last Posted Date
- 2023-03-03
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 747
- Registration Number
- NCT03475953
- Locations
- 🇫🇷
Centre Léon Bérard, Lyon, France
🇫🇷Institut Bergonié, Bordeaux, France
🇫🇷Institut Gustave Roussy, Villejuif, France
Effectiveness of Screening and Brief Interventions for Alcohol and Tobacco During Breast Cancer Treatment (ONKODETOX)
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-12-13
- Last Posted Date
- 2022-12-02
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 104
- Registration Number
- NCT03371732
- Locations
- 🇫🇷
Institut Bergonie, Bordeaux, France
© Copyright 2024. All Rights Reserved by MedPath